Estimating the incidence of autoimmune inflammatory arthritis after Lyme disease
- PMID: 40706260
- PMCID: PMC12326288
- DOI: 10.1016/j.semarthrit.2025.152797
Estimating the incidence of autoimmune inflammatory arthritis after Lyme disease
Abstract
Objective: A previous case series described the development of new autoimmune, inflammatory arthritis (IA) developing within 2 years of Lyme disease (LD). This study aimed to estimate the incidence of IA following LD using administrative claims data. Influenza, an infection not typically associated with post-infectious IA, was used for comparison.
Methods: We conducted a retrospective cohort study using the Johns Hopkins Health System administrative claims data from 01/2013-05/2024. Patients with LD and influenza were identified using International Classification of Diseases (ICD) codes, with LD cases further defined by requiring an antibiotic prescription within 30 days of the ICD code. IA cases were identified using 2+ ICD codes for rheumatoid arthritis, psoriatic arthritis or spondyloarthritis. Comparisons between infection groups were conducted using chi-square tests and Z-tests as appropriate. Logistic regression analyses were conducted to estimate the odds of IA development within two years of Lyme or influenza diagnosis, controlling for age and sex.
Results: The incidence of IA was significantly higher following LD compared to influenza (1.67 % vs 0.45 %, p < 0.0001), with the highest incidence of IA occurring within the first year after LD. Regression analysis showed LD was associated with increased odds of IA compared to influenza (OR 3.76, 95 % CI: 2.41-5.86, p < 0.001) after adjusting for age and sex.
Conclusion: The incidence of IA was higher within a year of LD infection, higher than that expected in the general population. The temporal association and elevated incidence support the need for prospective studies to elucidate mechanisms linking infection and autoimmunity in LD.
Keywords: Lyme disease, inflammatory arthritis.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: John B Miller reports financial support was provided by Rheumatology Research Foundation. John B Miller reports administrative support and article publishing charges were provided by Schadt Family. John B Miller reports financial support was provided by Johns Hopkins University Clinician Scientist Award. Ami A Shah reports financial support was provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases K24 AR080217. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
